FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 251 filers reported holding FATE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $711,000 | -18.1% | 12,000 | +20.0% | 8.60% | -37.1% |
| Q2 2021 | $868,000 | +31.5% | 10,000 | +25.0% | 13.69% | +28.4% |
| Q1 2021 | $660,000 | +123.7% | 8,000 | +146.9% | 10.66% | +131.9% |
| Q4 2020 | $295,000 | -95.2% | 3,240 | -97.9% | 4.60% | -21.2% |
| Q3 2020 | $6,127,000 | +14.8% | 153,297 | -1.4% | 5.84% | -0.2% |
| Q2 2020 | $5,335,000 | +49.2% | 155,505 | -3.4% | 5.85% | +35.2% |
| Q1 2020 | $3,575,000 | +12.8% | 160,959 | -0.6% | 4.33% | +4.1% |
| Q4 2019 | $3,170,000 | +172.1% | 161,977 | +116.0% | 4.16% | +283.4% |
| Q3 2019 | $1,165,000 | – | 75,000 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $46,987,000 | 60.92% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $278,604,000 | 36.08% |
| Darwin Global Management, Ltd. | 1,370,133 | $112,967,000 | 22.12% |
| Redmile Group, LLC | 12,957,222 | $1,068,323,000 | 15.05% |
| Copernicus Capital Management, LLC | 8,000 | $660,000 | 10.66% |
| Casdin Capital, LLC | 3,400,000 | $280,330,000 | 8.35% |
| Grosvenor Holdings, L.L.C. | 1,123,576 | $92,639,000 | 6.81% |
| DAFNA Capital Management LLC | 314,360 | $25,919,000 | 6.15% |
| Ally Bridge Group (NY) LLC | 270,000 | $22,262,000 | 4.27% |
| Ghost Tree Capital, LLC | 185,000 | $15,253,000 | 3.58% |